Consistent with our results, stevioside played an anti-inflammatory and immunomodulatory role in the human colon carcinoma cell line (Caco-2) by potentially suppressing lipopolysaccharide-induced pro-inflammatory cytokine TNF-α, IL-1β, and IL-6 productions [54]. This evidence concerns the gene IL6 and colon carcinoma.